ARO-HBV

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) develops medicines to treat intractable diseases. The company’s therapies trigger the RNA interference to alter target genes, as a natural process of gene silencing. What Happened Arrowhead announced entrance into a $3.7-billion license and...